Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03673046 · ClinicalTrials.gov registry record · NA

Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)

A NA study of Body Dysmorphic Disorder, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT03673046 is a NA study of Body Dysmorphic Disorder that has completed, run by Massachusetts General Hospital. The registered enrollment target is 80 participants, below the 142-participant average among 3 other Body Dysmorphic Disorder trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03673046, a NA study of Body Dysmorphic Disorder, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for body dysmorphic disorder (BDD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in body dysmorphic disorder symptom severity than those in the waitlist condition at treatment endpoint (week 12).

Conditions Studied

Interventions

  • DEVICE Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD)

Study Locations (1)

Massachusetts

  • Massachusetts General Hospital - Boston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2019-09-17
Est. Completion 2022-10-03
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT03673046

The ClinicalTrials.gov registry entry for NCT03673046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 142-participant average among 3 other Body Dysmorphic Disorder trials with a reported enrollment target (44% lower). The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Body Dysmorphic Disorder appearing as the primary indexed condition, and to 1 intervention - of which Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD) is the first listed.

NCT03673046 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03673046 about?

NCT03673046 is a clinical study titled "Waitlist-Control Trial of Smartphone Cognitive Behavioral Therapy (CBT) for Body Dysmorphic Disorder (BDD)". The investigators are testing the efficacy of Smartphone-delivered cognitive behavioral therapy (CBT) treatment for body dysmorphic disorder (BDD). The investigators hypothesize that participants receiving app-CBT will have greater improvement in body dysmorphic disorder symptom severity than those ...

What is the current status of trial NCT03673046?

This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-09-17. Estimated completion is 2022-10-03.

What conditions does trial NCT03673046 study?

This clinical trial studies the following conditions: Body Dysmorphic Disorder.

What interventions are being tested in trial NCT03673046?

The interventions under investigation include: Smartphone-delivered cognitive behavioral therapy (CBT) for body dysmorphic disorder (BDD) (DEVICE).

Who is sponsoring clinical trial NCT03673046?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03673046 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Body Dysmorphic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.